Adding budesonide to formoterol reduces risk of clinically important deteriorations (CID) in moderate to very severe COPD
| Main Authors: | , , , , , , |
|---|---|
| Format: | Conference item |
| Language: | English |
| Published: |
European Respiratory Society
2018
|